Richard Levy

Richard S.
Levy is currently a Non-Executive Director at Gliknik, Inc. since 2014.
Independent Director at Kiniksa Pharmaceuticals Ltd. since 2019.
Independent Director at Madrigal Pharmaceuticals, Inc. since 2016.
Independent Director at Kodiak Sciences, Inc. since 2018.
Independent Director at Protara Therapeutics, Inc. since 2019.
Independent Director at Kiniksa Pharmaceuticals International Plc since 2024.
Formerly an Independent Director at Aquinox Pharmaceuticals, Inc. from 2017 to 2019.
Independent Director at Constellation Pharmaceuticals, Inc. from 2020 to 2021.
Director at ArTara Subsidiary, Inc. from 2019 to 2020.
Vice President-Biologic Therapies at Celgene Corp.
from 2002 to 2003.
Chief Drug Development & Medical Officer, EVP at Incyte Corp.
from 2009 to 2016.
Vice President-Medical & Commercial Strategy at DuPont Pharmaceuticals Co. from 1997 to 2002.
Principal at Sandoz Corp.
in 1997.
Assistant Professor at David Geffen School of Medicine.
Assistant Professor at the University of California Los Angeles Graduate School.
Education includes undergraduate degree from Brown University, doctorate degrees from the University of Pennsylvania and Perelman School of Medicine.